$34.05
-0.04-0.12%
At close: -
$34.05
0.000.00%
After Hours: May 9, 4:00 PM EDT
Comments
Loading...
Harmony Biosciences Hldgs Stock Guidance | NASDAQ:HRMY | Benzinga
Harmony Biosciences Hldgs issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/06/2025 | HRMY | Harmony Biosciences Hldgs | FY | 2025 | — | — | — | $820.00M | $860.00M | $840.40M | Get Alert |
| 02/25/2025 | HRMY | Harmony Biosciences | FY | 2025 | — | — | — | $820.00M | $860.00M | $844.37M | Get Alert |
| 02/19/2025 | HRMY | Harmony Biosciences | FY | 2025 | — | — | — | $820.00M | $860.00M | $843.33M | Get Alert |
| 01/13/2025 | HRMY | Harmony Biosciences | FY | 2025 | — | — | — | $820.00M | $860.00M | $847.31M | Get Alert |
| 01/13/2025 | HRMY | Harmony Biosciences | FY | 2024 | — | — | — | $714.00M | $714.00M | $712.05M | Get Alert |
| 01/13/2025 | HRMY | Harmony Biosciences | Q4 | 2024 | — | — | — | $201.00M | $201.00M | $198.60M | Get Alert |
| 10/29/2024 | HRMY | Harmony Biosciences | FY | 2024 | — | — | — | $700.00M | $720.00M | $710.13M | Get Alert |
| 08/06/2024 | HRMY | Harmony Biosciences | FY | 2024 | — | — | — | $700.00M | $720.00M | $709.37M | Get Alert |
| 04/30/2024 | HRMY | Harmony Biosciences | FY | 2024 | — | — | — | $700.00M | $720.00M | $710.21M | Get Alert |
| 02/22/2024 | HRMY | Harmony Biosciences | FY | 2024 | — | — | — | $700.00M | $720.00M | $712.26M | Get Alert |
| 01/08/2024 | HRMY | Harmony Biosciences | Q4 | 2023 | — | — | — | $168.00M | $168.00M | $168.19M | Get Alert |
| 01/08/2024 | HRMY | Harmony Biosciences | FY | 2023 | — | — | — | $582.00M | $582.00M | $581.80M | Get Alert |
| 01/08/2024 | HRMY | Harmony Biosciences | FY | 2024 | — | — | — | $700.00M | $720.00M | $707.63M | Get Alert |
FAQ
What is the most recent guidance for Harmony Biosciences Hldgs (HRMY)?
There have been no specific sales or earnings guidance reported for Harmony Biosciences Hldgs in recent months.
Browse guidance and forecast on all stocks.
